↓ Skip to main content

Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year

Overview of attention for article published in Journal of Bone Metabolism, February 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year
Published in
Journal of Bone Metabolism, February 2021
DOI 10.11005/jbm.2021.28.1.51
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 2 13%
Lecturer 2 13%
Unspecified 1 7%
Student > Bachelor 1 7%
Student > Postgraduate 1 7%
Other 0 0%
Unknown 8 53%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 2 13%
Philosophy 1 7%
Unspecified 1 7%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Psychology 1 7%
Other 1 7%
Unknown 8 53%